What pathways and diseases are currently covered for the qBiomarker Somatic Mutation PCR Arrays?
FAQ ID -2922

The pathways covered include major receptor tyrosine kinase pathways, non-receptor kinase pathways, as well as additional oncogene and tumor suppressor pathways; and the targeted diseases include all major cancer types. In addition, a collection of more than 800 pre-validated somatic mutation assays enables researchers to study single mutations or to customize the mutation panels or collections according to their research needs.